Alkeran and Dupuytren's contracture - a phase IV clinical study of FDA data

Summary:

Dupuytren's contracture is found among people who take Alkeran, especially for people who are male, 60+ old.

The phase IV clinical study analyzes which people take Alkeran and have Dupuytren's contracture. It is created by eHealthMe based on reports of 5,416 people who have side effects when taking Alkeran from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.



On Jun, 05, 2022

5,416 people reported to have side effects when taking Alkeran.
Among them, 9 people (0.17%) have Dupuytren's contracture.


What is Alkeran?

Alkeran has active ingredients of melphalan. eHealthMe is studying from 5,427 Alkeran users for its effectiveness, alternative drugs and more.

What is Dupuytren's contracture?

Dupuytren's contracture (thickening of the fibrous tissue layer underneath the skin of the palm and fingers) is found to be associated with 435 drugs and 194 conditions by eHealthMe.

Number of Alkeran and Dupuytren's contracture reports submitted per year:

Could Alkeran cause Dupuytren's contracture?

Gender of people who have Dupuytren's contracture when taking Alkeran *:

  • female: 11.11 %
  • male: 88.89 %

Age of people who have Dupuytren's contracture when taking Alkeran *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 100 %

Common drugs people take besides Alkeran *:

  1. Zometa: 9 people, 100.00%
  2. Lisinopril: 9 people, 100.00%
  3. Colace: 9 people, 100.00%
  4. Aredia: 9 people, 100.00%
  5. Carvedilol: 9 people, 100.00%
  6. Celexa: 9 people, 100.00%
  7. Prednisone: 9 people, 100.00%
  8. Cytoxan: 9 people, 100.00%
  9. Pepcid: 9 people, 100.00%
  10. Lasix: 9 people, 100.00%

Common side effects people have besides Dupuytren's contracture *:

  1. Hyponatremia (abnormally low level of sodium in the blood; associated with dehydration): 9 people, 100.00%
  2. Physical Disability: 9 people, 100.00%
  3. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 9 people, 100.00%
  4. Cardiac Disorder: 9 people, 100.00%
  5. Fall: 9 people, 100.00%
  6. Cardiac Failure Congestive: 9 people, 100.00%
  7. Cardiac Valve Disease (heart valve disease): 9 people, 100.00%
  8. Coronary Heart Disease (narrowing or blockage of the coronary arteries): 9 people, 100.00%
  9. Nosebleed (bleeding from nose): 9 people, 100.00%
  10. Neuropathy Peripheral (surface nerve damage): 9 people, 100.00%

Common conditions people have *:

  1. Multiple Myeloma (cancer of the plasma cells): 1 person, 11.11%

* Approximation only. Some reports may have incomplete information.

Do you take Alkeran and have Dupuytren's contracture?

Check whether Dupuytren's contracture is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of Alkeran:

Dupuytren's contracture treatments and more:

COVID vaccines that are related to Dupuytren's contracture:

How severe was Dupuytren's contracture and when was it recovered:

Expand to all the drugs that have ingredients of melphalan:

Common drugs associated with Dupuytren's contracture:

All the drugs that are associated with Dupuytren's contracture:

All the conditions that are associated with Dupuytren's contracture:

How the study uses the data?

The study uses data from the FDA. It is based on melphalan (the active ingredients of Alkeran) and Alkeran (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: